Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Diabetes

Continuous glucose monitors: should people who don’t live with diabetes be wearing them?

Gwyneth Paltrow and other celebrities and influencers are sporting CGMs, but counting your glucose levels provides little benefit if you don’t have diabetes

The Guardian - AU

Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks

On Tuesday, Viking Therapeutics Inc. (NASDAQ:VKTX) released the much-awaited data from its Phase 2 trial of VK2735 pill, the company’s dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.

Benzinga

Ozempic price slashed following Donald Trump's demands - will it impact the UK cost?

Novo Nordisk said it has no plans to rise UK prices, despite pressure from Trump

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Half-off Ozempic? US patients paying in cash can now buy the popular weight-loss drug for less

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients

The Independent UK

Vegas teachers are getting lapband surgery paid for if they don’t put weight back on

Over 50 teachers in the Clark County School District have taken advantage of the program, which reimburses the $5,000 copay for bariatric surgery if they keep the weight off for five years.

The Independent UK

New study finally busts health myth of much-loved tropical fruit

Clinical trials replaced breakfast bread with a mango and monitored glycemic responses

The Independent UK

Patients warned not to turn to fake weight loss jabs after UK Mounjaro price hike

Pharmacists fear rise in sale of dangerous counterfeit medicines as drugmaker triples price of prescription

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Millions of people ‘could be denied weight-loss jabs due to flawed NHS guidance’

NHS BMI measures ‘don’t work for around 3 million patients’, a health analyst has warned

The Independent UK

Mounjaro weight-loss drug price to almost triple in UK after Trump complaint

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions

The Independent UK

Drug that slows onset of type 1 diabetes licensed for use in UK-first

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.

Evening Standard

Eli Lilly To Raise Mounjaro Price In UK, Expands Obesity Drug Push In India

Eli Lilly and Co. (NYSE:LLY) will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom, while expanding its market presence in India with a new injector pen.

Benzinga

Weighing The Costs: Obesity Drug Users Make Financial Sacrifices As Coverage Tightens

Vacations are on hold, dinners out skipped, and doses stretched — all so patients can keep taking weight-loss drugs like Wegovy and Zepbound as insurers pull back coverage in 2025.

Benzinga

UK Government, Eli Lilly Partner To Target Obesity Health Gaps

A new program to improve access to weight management services across the U.K. National Health Service (NHS) could benefit several obese patients.

Benzinga

Study links weight-loss drugs to serious eye conditions and vision loss

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye complications

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock

Tandem Diabetes Care Inc.’s (NASDAQ:TNDM) stock plunged on Thursday after the company cut its annual guidance.

The Independent UK

Hold the fries! How your favorite salty side can increase your risk of type 2 diabetes

The study found eating three servings of fries a week could increase your risk of developing type 2 diabetes by 20 percent

The Guardian - UK

Eating chips three times a week raises type 2 diabetes risk by 20%, study finds

Baking, boiling or mashing potatoes raises risk by 5% and replacing with whole grains lowers risk significantly

The Guardian - UK

Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply

Danish company to cut costs and consider layoffs after competition from Mounjaro and the copycat market

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Bryan Johnson Spent Millions To Be 18 Again—Says Novo Nordisk's Ozempic Anti-Aging Hype Is Misleading: 'Data Is Not There'

Tech entrepreneur Bryan Johnson, who spends $2 million annually on anti-aging treatments, refutes claims that Novo Nordisk AS‘s (NYSE:NVO) Ozempic demonstrates anti-aging properties. Johnson disputed a post on social platform X suggesting the diabetes drug reverses biological aging by 3.1 years.

The Independent UK

Ozempic could be hurting your gym gains — with potentially dangerous consequences

The Independent UK

Thousands of patients miss out on weight loss jab due to NHS ‘postcode lottery’

Doctors have warned that patients are being ‘set up for failure’ due to mismanagement of the rollout of Mounjaro

The Independent UK

Experts reveal potential side effect of Ozempic – and whether we should worry

Researchers found Ozempic-induced weight loss decreased muscle mass by about 10 per cent

The Independent UK

Avoiding these foods could help people lose twice as much weight, study finds

Those who were given a diet of pre-packaged breakfast bars and shop-bought sandwiches ate more calories than those who ate meals cooked from scratch

The Independent UK

Humans may have hibernation ‘superpowers’ in untapped genes, scientists say

Hibernating animals avoid muscle and nerve decay and stay healthy despite massive weight fluctuations

The Guardian - UK

Lucy Letby: Beyond Reasonable Doubt? review – one of the most meticulous documentaries in years

The science and statistics around Letby’s case are brilliantly unpacked by this considered programme. By its end, you are filled with questions

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Utah

28 stories

the National Institute for Health and Care Excellence

27 stories

GPHC

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.